CHAMPIONS ONCOLOGY, INC. Effective Income Tax Rate Reconciliation Gilti Percent
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Effective Income Tax Rate Reconciliation Gilti Percent of -6.40% for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent · last filed 2026-07-27
- CHAMPIONS ONCOLOGY, INC. effective income tax rate reconciliation gilti percent for fiscal 2026 was -6.40%, a 592.31% decline from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. effective income tax rate reconciliation gilti percent for fiscal 2025 was 1.30%.
| Period end | Effective Income Tax Rate Reconciliation Gilti Percent 12 month |
|---|---|
| 2026-04-30 | -6.40% 10-K · filed 2026-07-27 |
| 2025-04-30 | 1.30% 10-K · filed 2026-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |